Phase II Study of Nivolumab and Ipilimumab for Treatment of Metastatic/Recurrent Adenoid Cystic Carcinoma (ACC) of all Anatomic Sites of Origin and Other Malignant Salivary Gland T... by Young Kwang Chae, Richard Duan, Liam Il‐Young Chung, Youjin Oh, Borislav Alexiev, Sangwon Shin, Sukjun Kim, Irene Helenowski, Maria Matsangou, Victoria Villaflor, Devalingam Mahalingam

Get full text

Delta Radiomics and Tumor Size: A New Predictive Radiomics Model for Chemotherapy Response in Liver Metastases from Breast and Colorectal Cancer by Nicolò Gennaro, Moataz Soliman, Amir A. Borhani, Linda Kelahan, Hatice Savas, Ryan Avery, Kamal Subedi, Tugce A. Trabzonlu, Chase Krumpelman, Vahid Yaghmai, Young Chae, Jochen Lorch, Devalingam Mahalingam, Mary Mulcahy, Al Benson, Ulas Bagci, Yuri S. Velichko

Get full text

DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B by Keun-Wook Lee, Devalingam Mahalingam, Byoung Yong Shim, In-Ho Kim, Do-Youn Oh, Hope Uronis, Sun Jin Sym, Mohamad Sonbol, Khaldoun Almhanna, Mohamedtaki A. Tejani, Beodeul Kang, Michael H. Kagey, Melissa Stilian, Calvin Jia, Cynthia A. Sirard, Jaffer A. Ajani, Samuel J. Klempner

Get full text